ClinicalTrials.Veeva

Menu

Non-invasive Hemoglobin Monitoring in Cesarean Section

Seoul National University logo

Seoul National University

Status

Completed

Conditions

Placenta Previa

Treatments

Device: Masimo SpHb™ monitor

Study type

Interventional

Funder types

Other

Identifiers

NCT03409822
Hb Csec

Details and patient eligibility

About

Non-invasive hemoglobin monitoring will be performed in patients who underwent cesarean section with placenta previa and this will be compared with actual laboratory findings.

The investigators will investigate whether noninvasive hemoglobin monitoring can adequately reflect the massive bleeding that occurs within a short period of time and find out if it matches the actual laboratory findings.

Enrollment

39 patients

Sex

Female

Ages

20 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant woman
  • Elective Cesarean section
  • Placenta previa

Exclusion criteria

  • Decline of consent
  • Peripheral vascular disease
  • Cyanosis due to congenital heart disease
  • Refusal of transfusion
  • Mental retardation

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

39 participants in 1 patient group

Placenta previa
Other group
Treatment:
Device: Masimo SpHb™ monitor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems